ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $28,135 | -48.3% | 25,812 | -13.7% | 0.00% | -100.0% |
| Q3 2021 | $54,440 | -65.1% | 29,912 | -49.4% | 0.00% | -50.0% |
| Q2 2021 | $156,211 | -27.5% | 59,171 | -1.1% | 0.00% | -33.3% |
| Q1 2021 | $215,384 | +42.3% | 59,829 | -0.4% | 0.00% | +50.0% |
| Q4 2020 | $151,351 | -2.3% | 60,060 | -2.3% | 0.00% | -33.3% |
| Q3 2020 | $154,942 | -30.0% | 61,485 | -8.9% | 0.00% | -25.0% |
| Q2 2020 | $221,452 | +116.0% | 67,516 | +61.4% | 0.00% | +100.0% |
| Q1 2020 | $102,510 | -48.5% | 41,841 | -0.9% | 0.00% | -33.3% |
| Q4 2019 | $199,189 | -14.2% | 42,201 | -22.2% | 0.00% | -25.0% |
| Q3 2019 | $232,207 | -14.3% | 54,254 | +16.7% | 0.00% | -20.0% |
| Q2 2019 | $271,077 | +57.1% | 46,497 | +3.8% | 0.01% | +66.7% |
| Q1 2019 | $172,522 | +107.6% | 44,811 | +0.8% | 0.00% | +50.0% |
| Q4 2018 | $83,103 | -41.6% | 44,440 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $142,208 | -99.9% | 44,440 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $134,209,000 | -16.0% | 44,440 | +9.0% | 0.00% | 0.0% |
| Q1 2018 | $159,779,000 | +114848.9% | 40,760 | +21.4% | 0.00% | 0.0% |
| Q4 2017 | $139,000 | -74.8% | 33,572 | -62.2% | 0.00% | -50.0% |
| Q2 2017 | $552,000 | -1.8% | 88,717 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $562,000 | +23.8% | 88,717 | +4.6% | 0.00% | +33.3% |
| Q4 2016 | $454,000 | -10.1% | 84,831 | -5.5% | 0.00% | -25.0% |
| Q3 2016 | $505,000 | +2.6% | 89,763 | +0.3% | 0.00% | 0.0% |
| Q2 2016 | $492,000 | -17.6% | 89,527 | +11.2% | 0.00% | -20.0% |
| Q1 2016 | $597,000 | -10.8% | 80,524 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $669,000 | -7.9% | 80,524 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $726,000 | -24.8% | 80,524 | 0.0% | 0.01% | -28.6% |
| Q2 2015 | $966,000 | +26.8% | 80,524 | +13.8% | 0.01% | +16.7% |
| Q1 2015 | $762,000 | +149.0% | 70,750 | +17.3% | 0.01% | +200.0% |
| Q4 2014 | $306,000 | +92.5% | 60,334 | 0.0% | 0.00% | +100.0% |
| Q3 2014 | $159,000 | -34.6% | 60,334 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $243,000 | -12.0% | 60,334 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $276,000 | +5.3% | 60,334 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $262,000 | +10.1% | 60,334 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $238,000 | – | 60,334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |